Weidong Zhong, Ph.D.
President and Chief Executive Officer


Weidong Zhong is the CEO and co-founder of Terns Pharmaceuticals. Dr. Zhong is an accomplished industry veteran who brings over 20 years of experience and a proven track record in discovery and development of successful drug candidates. During his career, he played critical roles in advancing 15 small molecule candidates into the clinic. Prior to founding Terns Pharmaceuticals, Dr. Zhong served as Executive Director and Global Head of Antiviral Research at Novartis Institutes for BioMedical Research. At Novartis, he oversaw drug discovery activities spanning multiple viral disease areas and established a strong pipeline of both small molecules and biologics. Prior to Novartis, he served as the Senior Director of Biology at Gilead Sciences where he led discovery and early stage research projects to combat significant viral pathogens and liver disease. Early in his career, Dr. Zhong held positions of increasing responsibility at Ribapharm, ICN Pharmaceuticals, Schering-Plough Research Institute, and SmithKline Beecham.

Dr. Zhong received his Ph.D. in Biochemistry from the University of Wisconsin, Madison, and conducted postdoctoral research at University of California, San Francisco.